Aberdeen Disposes of Shares of Medivolve and Ceases to Be an Insider

TORONTO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB) announces that it has sold 7,000,000 common shares of Medivolve Inc. (“Medivolve”) (NEO: MEDV) on September 22, 2022, which has resulted in Aberdeen’s ownership being reduced by 1.7% to less than 10% of the outstanding Medivolve common shares and Aberdeen ceasing to be an insider of Medivolve

Read more at globenewswire.com